These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 26958338)

  • 1. Tolerability of the SQ-standardised grass sublingual immunotherapy tablet in patients treated with concomitant allergy immunotherapy: a non-interventional observational study.
    Reiber R; Keller M; Keller W; Wolf H; Schnitker J; Wüstenberg E
    Clin Transl Allergy; 2015; 6():9. PubMed ID: 26958338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and tolerability of an intra-seasonal initiation of the SQ-standardised grass allergy immunotherapy tablet: a non-interventional observational study investigating the feasibility during routine administration.
    Schwab JA; Wolf H; Schnitker J; Wüstenberg E
    Clin Drug Investig; 2013 Oct; 33(10):719-26. PubMed ID: 23943141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerability of an Immunologically Enhanced Subcutaneous Immunotherapy Preparation in Patients Treated with Concomitant Allergy Immunotherapy: A Non-Interventional Observational Study.
    Reiber R; Wolf H; Schnitker J; Wüstenberg E
    Drugs Real World Outcomes; 2017 Mar; 4(1):65-74. PubMed ID: 28070824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-Seasonal Initiation of the SQ-Standardised Grass Allergy Immunotherapy Tablet Routinely Applied by Allergy Specialists and General Practitioners with Experience in Treatment of Allergy: A Non-Interventional Observational Study.
    Schwab JA; Wolf H; Schnitker J; Wüstenberg E
    Pulm Ther; 2018 Jun; 4(1):45-57. PubMed ID: 32026241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD).
    Pfaar O; Bachert C; Bufe A; Buhl R; Ebner C; Eng P; Friedrichs F; Fuchs T; Hamelmann E; Hartwig-Bade D; Hering T; Huttegger I; Jung K; Klimek L; Kopp MV; Merk H; Rabe U; Saloga J; Schmid-Grendelmeier P; Schuster A; Schwerk N; Sitter H; Umpfenbach U; Wedi B; Wöhrl S; Worm M; Kleine-Tebbe J; Kaul S; Schwalfenberg A
    Allergo J Int; 2014; 23(8):282-319. PubMed ID: 26120539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An observational, real-life safety study of a 5-grass pollen sublingual tablet in children and adolescents.
    Eberle P; Brueck H; Gall R; Hadler M; Sieber J; Karagiannis E
    Pediatr Allergy Immunol; 2014 Dec; 25(8):760-6. PubMed ID: 25378225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
    Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
    Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-Related Quality of Life During Routine Treatment with the SQ-Standardised Grass Allergy Immunotherapy Tablet: A Non-Interventional Observational Study.
    Horn A; Zeuner H; Wolf H; Schnitker J; Wüstenberg E;
    Clin Drug Investig; 2016 Jun; 36(6):453-62. PubMed ID: 26979593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world, long-term effectiveness of allergy immunotherapy in allergic rhinitis: Subgroup analyses of the REACT study.
    Contoli M; Porsbjerg C; Buchs S; Larsen JR; Freemantle N; Fritzsching B
    J Allergy Clin Immunol; 2023 Aug; 152(2):445-452.e4. PubMed ID: 36871918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability of the SQ Tree SLIT Tablet in Adults.
    Birk AO; Andersen JS; Villesen HH; Steffensen MA; Calderon MA
    Clin Ther; 2017 Sep; 39(9):1858-1867. PubMed ID: 28844318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimum treatment strategies for polyallergic patients - analysis of a large observational trial.
    Shah-Hosseini K; Mioc K; Hadler M; Karagiannis E; Mösges R
    Curr Med Res Opin; 2015 Dec; 31(12):2249-59. PubMed ID: 26366617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy With the SQ Tree SLIT-tablet in Adults and Adolescents With Allergic Rhinoconjunctivitis.
    Mäkelä MJ; Gyllfors P; Valovirta E; Steffensen MA; Grønager PM; Savolainen J; Winther L
    Clin Ther; 2018 Apr; 40(4):574-586.e4. PubMed ID: 29551533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergy immunotherapy tablet: Grazax® for the treatment of grass pollen allergy.
    Senna GE; Calderon M; Milani M
    Expert Rev Clin Immunol; 2011 Jan; 7(1):21-7. PubMed ID: 21162646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and tolerability of 5-grass pollen tablet sublingual immunotherapy: pooled analysis and clinical review.
    Didier A; Bons B
    Expert Opin Drug Saf; 2015 May; 14(5):777-88. PubMed ID: 25732009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of Timothy Grass Sublingual Immunotherapy Tablet in Children: Pooled Analyses of Clinical Trials.
    Halken S; Roberts G; Valovirta E; Nolte H; Hulstrøm V; Blaiss MS
    J Allergy Clin Immunol Pract; 2020 Apr; 8(4):1387-1393.e2. PubMed ID: 31954191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of a SQ-standardised grass allergen tablet for sublingual immunotherapy: a randomized, placebo-controlled trial.
    Kleine-Tebbe J; Ribel M; Herold DA
    Allergy; 2006 Feb; 61(2):181-4. PubMed ID: 16409193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SQ grass sublingual allergy immunotherapy tablet for disease-modifying treatment of grass pollen allergic rhinoconjunctivitis.
    Dahl R; Roberts G; de Blic J; Canonica GW; Kleine-Tebbe J; Nolte H; Lawton S; Nelson HS
    Allergy Asthma Proc; 2016; 37(2):92-104. PubMed ID: 26802643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral/sublingual Phleum pretense grass tablet (Grazax/Grastek) to treat allergic rhinitis in the USA.
    Nelson HS
    Expert Rev Clin Immunol; 2014 Nov; 10(11):1437-51. PubMed ID: 25340426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Budget impact analysis of two immunotherapy products for treatment of grass pollen-induced allergic rhinoconjunctivitis.
    Rønborg SM; Svendsen UG; Micheelsen JS; Ytte L; Andreasen JN; Ehlers L
    Clinicoecon Outcomes Res; 2012; 4():253-60. PubMed ID: 23166443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of sublingual immunotherapy Timothy grass tablet in subjects with allergic rhinitis with or without conjunctivitis and history of asthma.
    Maloney J; Durham S; Skoner D; Dahl R; Bufe A; Bernstein D; Murphy K; Waserman S; Berman G; White M; Kaur A; Nolte H
    Allergy; 2015 Mar; 70(3):302-9. PubMed ID: 25495666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.